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Dear Sir, 
The recent advancement of knowledge and management strategies of patients with autoimmune 
conditions such as systemic sclerosis (SSc), inflammatory arthritis, and systemic lupus 
erythematosus (SLE)  achieved during the last years lead to the clear-cut improvement of patients' 
quality of life and reduced long-term disability [1–5]. Nowadays, new imaging techniques in 
autoimmune-rheumatic diseases are expanding the possibilities to achieve an early diagnosis, an 
appropriate follow-up, evaluation of disease activity, monitoring, and response to treatment in the 
affected patients. Among these techniques, infrared thermography represents a promising tool in 
order to assess vascular and joint involvement in autoimmune patients.   
Since the initial enthusiasm in medical use of thermal photography over 2 decades ago, only few 
clinical practical applications were developed until past years, when the technical quality of 
available imaging systems advanced immensely. Improved data quality enhances the capability for 
detecting diagnostically relevant information in the thermal images and reduces human errors and 
variations in the image interpretation. 
Modern thermal imaging systems are equipped to detect this radiation and can be used to form a 
dynamic map of temperature distribution at a surface. In brief, infrared camera generates images 
with thermal data in real time, and it is possible in a fraction of a second to image large areas of the 
human body, for example all the joints of both hands. 
Thermal cameras images can be taken as a pseudo-measure of blood flow due to the convection of 
heat from the blood vessels in the skin and muscle in response to thermoregulation. 
Moreover, as infrared thermography can give an indirect measure of blood flow and articular 
inflammation, it can be useful to assess peripheral vasculopathy and synovitis in active rheumatic 
arthritis, both at baseline and in response to treatment.  
1. Arthritis 
Synovitis represents the cardinal sign of arthritis, and therefore its assessment in patients with 
inflammatory arthritis is a major issue for proper treatment. The complementary methods of images 
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have become increasingly relevant, being the magnetic resonance imaging (MRI) and ultrasound 
(US) widely used for this purpose. Nevertheless, both techniques have several limitations and the 
need for an ideal imaging method is still a matter of research.  
In this context, thermography represents a promising imaging tool which has been not yet 
exhaustively explored.  
Among others, Collins and Cosh and Ring and Collins [6,7] showed that the surface temperature of 
an arthritic joint was related to the temperature in intra-articular joint, and to other serological 
markers of inflammation. More recently, Brenner and colleagues demonstrated that changes 
observed in the thermal signature correlated with disease severity in rodent models of mono-
arthritis and systemic autoimmune arthritis, suggesting that the novel thermal imaging techniques 
could provide useful and objective measurements of joint inflammation based on two cardinal 
inflammatory signs: joint swelling/edema (joint diameters) and warmth [8] (Figure 1a). New 
thermal imaging devices have shown to be effective at detecting changes in temperature in the 
context of inflammation and arthritis in in vivo models [9].  
An early detection of articular inflammation, even before a definitive diagnosis is established, can 
be crucial, since starting an appropriate treatment at early stages of the pathological process seems 
to prevent disease persistence, joint destruction, and long-term disability [10].  
Assessment of thermal imaging could be an easy to use and cost-effective technique in the general 
clinical practice especially when firstly assessing a new onset of arthalgia in patients suspected for 
rheumatic diseases. Critically, it might represent a tool to investigate the presence of active joint 
inflammation in the armamentarium of general practitioners when considering referring a patient for 
a rheumatologic evaluation and when high resolution ultrasound examination is not available or 
pending. Nevertheless, larger studies are still needed to confirm and validate the usefulness of 
thermography in this setting as the previous studies centered mainly in exploring the thermographic 
differences between arthritic patients and healthy subjects.  
2. Critical Digital Ischemia 
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Critical digital ischemia is a rare but serious complication of rheumatic diseases, mainly systemic 
sclerosis (SSc). It is characterized by the obstruction of the arterial flow, which causes severe pain 
at rest, compromising tissue viability, potentially leading to ulceration, gangrene, and ultimately 
amputation. In patients with SSc, this complication is the result of both progressive 
microangiopathy and digital artery vasculopathy [11], rather than to large vessel disorder which 
occurs in patients with atherosclerotic peripheral disease. 
It is well recognized that microvascular changes can be easily demonstrated by nailfold 
capillaroscopy, which cannot provide yet functional measure of blood flow [12].  
Clinical assessment and investigation need to center on establishing the underlying cause, in order 
to optimize treatment strategies. However, to date, the overall management of patients affected by 
critical digital ischemia is difficult for the treating clinician and new tools both for diagnosis and 
monitoring ongoing treatment are highly needed. Infrared thermal system has been previously 
applied as non-invasive monitoring tool that provides real-time screening information of tissue 
perfusion based on infrared thermal signals. Therefore, the use of thermal imaging might be an 
additional tool to assess critical digital ischemia and to monitor it during therapy (Figure 1b). 
Therefore, this approach might potentially provide helpful supplementary information about tissue 
perfusion in patients suffering from SSc and in those patients who experience this severe 
complication. Further studies are warranted to validate the diagnostic and the reproducibility of the 
approach. 
3. Systemic Lupus Erythematosus 
Systemic lupus erythematosus (SLE) is characterized by a broad spectrum of clinical manifestations 
enfolding different tissues and organs at the onset and during the course of the disease. Among 
these, the presence of synovitis, meaning “non-erosive arthritis” involving ≥2 peripheral joints, 
characterized by tenderness, swelling or effusion or “inflammatory synovitis” in ≥ 2 joints 
characterized by: a) swelling or effusion, or b) tenderness and 30 minutes of morning stiffness [13] 
are included in the classification criteria. The joint involvement in SLE is non-erosive, non-
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deforming arthralgias/arthritis primarily affecting small joints of both hands, wrists and knees, and 
few patients show a major synovitis indistinguishable from rheumatoid arthritis (RA), the so-called 
“rhupus”.  
A number of techniques are available in order to objectify inflammation and joint swelling, such as 
MRI, which however is expensive and not practical for repetitive use. The use of high-resolution 
US examination represents a reliable technique when performed by expert and trained operators. 
However, it is not always available outside rheumatologic practise or might request a further 
referral. Assessment of thermal imaging could be a useful, easy to perform and cost-effective tool to 
be applied in both general and rheumatic settings in order to improve the management of patients 
with SLE complaining for arthalgia, providing a fast and reproducible methods with the potential to 
guide therapeutic choices (Figure 1c).   
4. Systemic Sclerosis 
SSc is a chronic autoimmune disorder with high morbidity and mortality. The pathogenesis of the 
disease is characterized by the presence of both micro- and macro-vascular damage and fibrosis. 
Skin lesions represent the leading feature of the disease and Raynaud’s phenomenon (RP) is the 
most frequent and early clinical manifestation. Digital vasculopathy severely affects SSc patients, 
negatively impacting on their daily functions. In addition, recent evidences have shown that the 
presence of digital ulcers at the beginning of the disease is associated with poor cardiovascular 
prognosis and decreased survival rate [14]. Nevertheless, adequate treatment strategies for the 
management of RP and skin manifestations are lacking, mainly due to the absence of reliable 
outcome measures in clinical trials [15]. Therefore, identifying new tools for an early diagnosis and 
monitoring of vasculopathy in SSc patients represents an urgent clinical need. Moreover, the recent 
development of new therapeutic agents makes this need even more important in order to assess their 
efficacy in preventing and treating skin and vascular involvement in this setting. In fact, as stated 
before, even if nailfold capillaroscopy has been already validated as an accountable tool for the 
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analysis of those structural changes that can differentiate between primary and secondary RP, it 
cannot provide functional analysis of blood flow.  
Previous studies have evaluated the possible role of infrared thermography imaging for the 
assessment of vascular damage and RP in affected patients [16–19], but its role needs further 
validation in SSc setting and its use in monitoring the clinical evolution and/or response to therapy 
has been only anecdotally explored.  
Therefore, in order to evaluate the efficacy of infrared thermography in the assessment of peripheral 
vasculopathy in a cohort of SSc patients treated with cyclic intravenous infusions with synthetic 
analogue of prostacyclin (Iloprost), we designed this pilot prospective study. Critically, taking into 
account the lack of standard protocol timing the use of synthetic prostanoids for SSc patients, we 
also aimed to identify those patients who might benefit from an intensified infusional treatment 
protocol with prostanoids. For the sake of this study, we enrolled patients diagnosed with SSc [20], 
attending the San Giovanni Bosco Hospital of Turin (Italy) for their routinely 28-days apart 
intravenous therapy with Iloprost based on the presence of severe secondary RP and/or digital 
ulcers.  Thermographic evaluation of both hands was performed at baseline (T0) before prostanoid 
infusion, and at days 14 and 28 after the first prostanoid infusion (named T1 and T2, respectively). 
For the thermographic recordings, a digital infrared camera FLIR ONE (FLIR Systems Inc., USA) 
was used. The acquired thermal images were analyzed with software dedicated to thermographic 
analysis FLIR Tools (FLIR Systems Inc., USA). Camera was placed on horizontal surface at 1 m 
distance (field of view 25° × 19°) perpendicular to skin surface. The significance of baseline 
differences was determined by the chi-squared test, Fisher’s exact test or the unpaired t-test, as 
appropriate. A two-sided P-value <0.05 was statistically significant. All statistical analyses were 
performed using SPSS version 19.0 (IBM, Armonk, NY, USA). As result, among the 26 enrolled 
patients, 24 (92.3%) were female, mean age was 65.3 ±12.6 years, and mean disease duration at 
time of data collection was 12.4 ±6.6 years. Fifteen patients (57.7%) presented with a limited 
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cutaneous form of SSc, while 11 patients (42.3%) showed a diffuse cutaneous form of SSc with a 
high rate of interstitial lung disease as high as 63.6%. The thermographic assessment showed a 
substantial stability of the temperature values when comparing T0 and T1 (mean differences of the 
right hands 0.4 ±5.6; mean differences of the left hands 1.2 ±4.5), while they are significantly 
reduced when comparing T1 and T2 (mean differences of the right hands -3.1 ± 9.3, p=0.049; mean 
differences of the left hands -3.4 ±8.5, p=0.012) (Figure 2a). When stratifying according to clinical 
manifestation, a higher difference in temperature variations were observed between T1 and T2 in 
patients with diffuse cutaneous SSc, when compared to those with limited cutaneous SSc (mean of 
the differences of the right hands -5.0 ±11; mean of left-hands differences -4.9 ±11.5 Vs. mean 
right-hands differences -2.5 ±11; mean left-hands differences -3 ±8.6; p=0.035 respectively) (Figure 
2b).  
5. Conclusion and future prospective 
Autoimmune rheumatic diseases are a heterogeneous group of chronic pathologic conditions 
affecting joints and connective tissue, often leading to permanent damage and disability, lowering 
the quality of life of the affected patients. An early diagnosis, an appropriate therapeutic strategy 
and monitoring are therefore mandatory and highly needed. In this setting, infrared thermography 
might represent a reliable, non-invasive, portable, and cost-effective diagnostic tool both in expert 
centers and in general practice.  Moreover, although limited, the results of this prospective pilot 
study seem very promising to reinforce the role of thermography as suitable outcome measure of 
novel treatments for SSc-related RP and vasculopahy in clinical trials. Moreover, these data show 
that patients with diffuse cutaneous form of SSc could benefit more from an intensified infusion 
protocol with prostanoids compared to those SSc patients with a limited cutaneous form of the 
disease. Indeed, further longitudinal studies are needed in order to assess the validity and the 
reproducibility of this technique. 
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